Mr. Yan-Shen Lin has been General Manager of United Orthopedic Corporation since June 30, 2008 and serves as its Chairman and President and has been its Director since March 5, 1993. Mr. Lin serves as Chai...

取締役

名称	ポジション	在職期間	報酬	所有権
Yan-Shen Lin	Chairman & President	31.3yrs	データなし	3.33% NT$ 362.8m
Chun-Sheng Lin	Director	18yrs	データなし	2.07% NT$ 225.5m
Hai-Yen Hau	Director	27.1yrs	データなし	0.79% NT$ 86.3m
Ng Chor Wah	Director	19yrs	データなし	1.73% NT$ 188.8m
Li-Ju Chen	Independent Director	no data	データなし	データなし
Te-Chien Lin	Director	4yrs	データなし	データなし
Chien-Lin Liu	Independent Director	4yrs	データなし	データなし
Kun-Chang Lee	Independent Director	4yrs	データなし	データなし
Meng-Ta Wu	Independent Director	4yrs	データなし	データなし

11.0yrs

平均在職期間

経験豊富なボード: 4129の取締役会は経験豊富で経験豊富です ( 11年の平均在任期間)。

United Orthopedic マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

United Orthopedic Corporation Announces Change in President

United Orthopedic Corporation Announces Establishment of Strategy Committee, Effective July 1, 2024

United Orthopedic Corporation, Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Dividend increased to NT$4.00

United Orthopedic Corporation Announces Change in President

United Orthopedic Corporation Announces Establishment of Strategy Committee, Effective July 1, 2024

First quarter 2024 earnings released: EPS: NT$0.98 (vs NT$0.85 in 1Q 2023)

United Orthopedic Corporation to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: NT$4.50 (vs NT$2.84 in FY 2022)

United Orthopedic Corporation, Annual General Meeting, Jun 18, 2024

Investor sentiment improves as stock rises 15%

New minor risk - Shareholder dilution

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Second quarter 2023 earnings released: EPS: NT$0.97 (vs NT$0.32 in 2Q 2022)

Upcoming dividend of NT$2.28 per share at 3.0% yield

Price target increased by 9.1% to NT$88.33

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: NT$2.84 (vs NT$0.37 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: NT$0.32 (vs NT$0.025 in 2Q 2021)

First quarter 2022 earnings released: EPS: NT$0.46 (vs NT$0.074 loss in 1Q 2021)

Price target decreased to NT$31.00

Less than half of directors are independent

Third quarter 2021 earnings released: EPS NT$0.05 (vs NT$0.49 in 3Q 2020)

Upcoming dividend of NT$0.84 per share

Second quarter 2021 earnings released: NT$0.04 loss per share (vs NT$0.063 profit in 2Q 2020)

First quarter 2021 earnings released: NT$0.07 loss per share (vs NT$0.17 loss in 1Q 2020)

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Full year 2020 earnings released: EPS NT$1.00 (vs NT$1.05 in FY 2019)

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Is United Orthopedic (GTSM:4129) A Risky Investment?

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

New 90-day low: NT$33.05

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

New 90-day high: NT$36.05

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: NT$35.60

Third quarter 2020 earnings released: EPS NT$0.49

New 90-day low - NT$33.05

First half earnings released

Upcoming Dividend of NT$0.82 Per Share

CEO（最高経営責任者

在職期間

取締役

平均在職期間

マネジメント基準チェック /14